Customer Centricity: A Crucial Aspect That Is Transforming the Pharmaceutical Industry

Customer Centricity: A Crucial Aspect That Is Transforming the Pharmaceutical Industry

Tuesday, October 28, 2025 1:15 PM to 1:40 PM · 25 min. (CET)
Hall 12.1 - 12.1C68
Future of Pharma & Ingredients
ManufacturingSupply ChainMarket Insights

Information

In an era where patient outcomes and satisfaction are paramount, placing the customer at the heart of our strategy and operations is not just beneficial but essential.

Understanding Customer Centricity: customer centricity means prioritising the needs and experiences of our customers – patients, healthcare providers, and caregivers – throughout every stage of the pharmaceutical lifecycle. It involves understanding their needs, preferences, and challenges, and using this knowledge to guide our decisions and actions.

Why Customer Centricity Matters: focusing on patient-centric approaches leads to improved health outcomes, enhanced trust and loyalty, regulatory compliance, market differentiation, and feedback-driven innovation.

Recent Industry Trends: AI is revolutionising drug discovery, digital health technologies are enhancing personalized medicine, emerging therapeutic modalities are expanding treatment options, precision medicine is tailoring therapies to genetic profiles, and patient engagement is driving better health outcomes and satisfaction.

Challenges in Implementing Customer Centricity: The main challenges in implementing a customer-centric approach include data silos, resistance to change, regulatory and compliance issues, technology integration, and measuring success. Implementing Customer Centricity: Actively involving patients, collaborating with healthcare providers, integrating technology, and continuously improving strategies based on feedback are key to enhancing customer centricity in healthcare. Conclusion: In conclusion, customer centricity is not just a buzzword; it is a fundamental shift in how we operate in the pharmaceutical industry. By putting our customers at the centre of everything we do, we can improve patient outcomes, build trust, comply with regulations, differentiate ourselves in the market, and drive innovation.

Let us commit to this approach and work together to create a healthier, more patient-focused future.

Sector
Supply Chain
Siegfried AG6.0B6Siegfried is a preferred partner for complete integrated Drug Substance and Drug Product services with production capabilities worldwide. Creating, improving and manufacturing formulations is our passion. Our professionalism is pivotal for your project throughout the entire life cycle. Our offering, the combination of inherited technical know-how and expertise, is unique for a supplier of development and manufacturing services. Our Drug Substance services include Custom Development and Contract Manufacturing for both APIs and intermediates. In addition, we offer a multiclient API portfolio (including controlled substances) with drug master files and patented technologies. Our Drug Product clients benefit from a broad spectrum of dosage forms and technologies like oral solids, inhalative products, opthalmics and sterile ointments. Drug Product services include Custom Development and Contract Manufacturing for the dosage forms mentioned above. Siegfried enhanced its Drug Product capabilities with the acquisition of two Novartis sites near Barcelona and the establishment of a center of excellence for developing and optimizing formulations. Thus, we expanded our competency with high potent Drug Product development and manufacturing down to an OEL of 1Mug/m3, next to capsules with APIs (down to 0.1 Mug/m3). Complex oral drug delivery systems or solubility increasing of APIs (e.g. nanomilling or spray drying) belong to our core competences. In the field of steriles, we are experienced with fill and finish of vaccines and biologic compounds. Furthermore, we can offer dry powder inhalator capsules. Siegfried has 11 GMP approved sites worldwide spanning both the eastern and western hemispheres. Our Drug Substance sites are located in Zofingen (Switzerland), Pennsville (US), Nantong (China), Minden (Germany), Evionnaz (Switzerland) and St. Vulbas (France). Our Drug Product locations are in H...

Join the event!

See all the content and easy-to-use features by logging in or registering!